Endo Counts On Vasostrict Revenues Despite Competition
As Company Focuses On ‘Optimizing’ Its Generics Business
Endo still sees significant potential in Vasostrict despite the onset of competition. Meanwhile, the firm says it is focusing on “optimizing” its generics business.
